The Impact of MS-Related Cognitive Fatigue on Future Brain Parenchymal Loss and Relapse: A 17-Month Follow-up Study.

Front Neurol · 2016 · PMC5030297 · PMID 27708613

Europe PMC DOI

hedged sentences

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

failed to reach significancep = 0.089so close (0.05 < p ≤ 0.1)

The number of MS patients, receiving disease-modifying drugs, divided into those with classical interferons and those receiving escalating treatments with Natalizumab or Fingolimod, failed to reach significance [χ(2) = 4.827, p = 0.089] (see Table 1 ).

also in 4,113 other papers

did not reach statistical significanceno p-value reported

In our view, the fact that changes in the lateral ventricle volume and the diffusivity of the corpus callosum did not reach statistical significance is only due to the reduction of the sample size by focusing only on relapsing-remitting patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.